Presentation is loading. Please wait.

Presentation is loading. Please wait.

Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study  Victor Shi, Michele Senni, Hendrik.

Similar presentations


Presentation on theme: "Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study  Victor Shi, Michele Senni, Hendrik."— Presentation transcript:

1 Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study  Victor Shi, Michele Senni, Hendrik Streefkerk, Vikas Modgill, Wenchun Zhou, Allen Kaplan  International Journal of Cardiology  Volume 264, Pages (August 2018) DOI: /j.ijcard Copyright © 2018 The Authors Terms and Conditions

2 Fig. 1 Overall and confirmed cases of angioedema: patient flow.
AAC, angioedema adjudication committee. *No cases of hospitalization required mechanical support. International Journal of Cardiology  , DOI: ( /j.ijcard ) Copyright © 2018 The Authors Terms and Conditions

3 Fig. 2 Kaplan-Meier plot of time to first AAC-confrimed angioedema event during the double-blind phase. International Journal of Cardiology  , DOI: ( /j.ijcard ) Copyright © 2018 The Authors Terms and Conditions


Download ppt "Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study  Victor Shi, Michele Senni, Hendrik."

Similar presentations


Ads by Google